Evidence map›Paper›PMID 10579699›Full record

ArticleGlycoconjugate journal1999

Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence.

A P Corfield, N Myerscough, B F Warren, P Durdey, C Paraskeva, R Schauer

Abstract read
PubMed Publisher
In one paragraph

Article in Glycoconjugate journal, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Role of Sialyl-Cells · 2021
    Article
  9. Review
  10. Profiling ofInternational journal of molecular sciences · 2020
    Article
  11. NK Cell-Based Immune Checkpoint Inhibition.Frontiers in immunology · 2020
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Exploration of the Sialic Acid World.Advances in carbohydrate chemistry and biochemistry · 2018
    Review
  18. mBio · 2017
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

A P CorfieldUniversity Department of Medicine, Bristol Royal Infirmary, UK. Tony.Corfield@bristol.ac.uk
N Myerscough
B F Warren
P Durdey
C Paraskeva
R Schauer
Bristol Royal Infirmary · GBKiel University · DEUniversity of Bristol · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oligo-O-acetylation of sialic acids found in normal colonic mucins is greatly reduced in colorectal cancer. Mucins prepared from cancer tissue in adenocarcinoma showed this reduction, while normal O-acetylation was detected in resection margin and control cases and total mucin sialic acid content was significantly decreased in cancer vs. control samples. A reduction of the O-acetyl transferase activity catalysing the O-acetylation reaction was also found. A series of cultured human colorectal cell lines derived from the same premalignant adenomatous line, and representative of the adenoma-carcinoma sequence were examined and revealed a depletion of oligo-O-acetylation in the original diploid premalignant line, re-expression in a further premalignant line and reduction in malignant mucinous and adenocarcinoma cell lines. Reduction of sialic acid O-acetylation appears as an early event in the process of malignant transformation in human colorectal cancer.

Indexed as

AcetylationAcetyltransferasesAdenocarcinomaChromatography, High Pressure LiquidChromatography, Thin LayerColorectal NeoplasmsEpitopesHumansMucinsN-Acetylneuraminic AcidTumor Cells, CulturedAcetyltransferasesEpitopesMucinsN-Acetylneuraminic Acid

Identifiers

PMID10579699
OpenAlexW15718524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.